Prevalence of Amyloid Positron Emission Tomographic Positivity in Poststroke Mild Cognitive Impairment
Author(s) -
Frank A. Wollenweber,
Sonja Därr,
Claudia Müller,
Marco Duering,
Katharina Büerger,
Vera Zietemann,
Rainer Malik,
Matthias Brendel,
Birgit ErtlWagner,
Peter Bartenstein,
Axel Rominger,
Martin Dichgans
Publication year - 2016
Publication title -
stroke
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.397
H-Index - 319
eISSN - 1524-4628
pISSN - 0039-2499
DOI - 10.1161/strokeaha.116.013778
Subject(s) - medicine , dementia , stroke (engine) , positron emission tomography , prospective cohort study , magnetic resonance imaging , amyloid (mycology) , neuroimaging , standardized uptake value , cohort , pathology , nuclear medicine , radiology , psychiatry , disease , mechanical engineering , engineering
Mild cognitive impairment (MCI) is common after stroke and associated with poor outcome. However, the mechanisms underlying poststroke MCI (PS-MCI) are insufficiently understood. We performed amyloid-β positron emission tomography (PET) in a prospective cohort of stroke survivors to determine the role of amyloid pathology in PS-MCI.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom